iShares Hang Seng TECH ETF (03067.HK) Rose 0.20% to 10.190
Newtimespace News, as of 09:55 on May 19, iShares Hang Seng TECH ETF (03067.HK) was quoted at HKD 10.190, up 0.20%. The ETF opened at HKD 10.160, with a high of HKD 10.260 and a low of HKD 10.130. The latest Net Asset Value (NAV) per unit is HKD 10.185, with a premium rate of -0.15%. The asset size is approximately HKD 15.17 billion.
iShares Hang Seng TECH ETF (03067.HK) tracks the Hang Seng Tech Index, which is compiled and published by Hang Seng Indexes Company Limited. The index aims to reflect the performance of leading companies in the technology or innovation sectors listed in Hong Kong and is another flagship index following the Hang Seng Index and the Hang Seng China Enterprises Index. The index covers technology fields such as semiconductor chips, AI large models, cloud computing, and smart vehicles, and includes industry giants like Alibaba, Meituan, Tencent Holdings, and Xiaomi Group. The index uses a free-float adjusted market capitalization weighting method and has strict innovation screening criteria. It is one of the core market benchmarks reflecting the trend of Hong Kong's technology sector.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- Biotech Index Hits a Year-to-Date High as Innovative Drug and CXO Names Rally; CSOP Hang Seng Biotech ETF (3174.HK) Gains 3.18% and Is Up 17.93% Year-to-Date
- Korean Stocks Open Higher but Close Lower as Semiconductor Heavyweights Slip; Csop Kospi 200 Etf (03121.HK) Falls 1.30%
- KINETIC DEV (01277.HK): Sierra Leone Rutile Project Commences Production
- CNE TECH CORP (00611.HK): Acquisition Consideration Adjusted Down to RMB71.93m
- BEONE MEDICINES (06160.HK): Grants RSUs Over 52,482 ADSs to 277 Grantees